Healthcare ETF ASX | Health Sector ETF | BetaShares
  • Request info pack
  • Download Factsheet
  • Request a call
  • Request Lonsec research
  • View all funds
  • Download Factsheet

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

Fund Objective

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Benefits of DRUG

Healthcare – a global growth opportunity

Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.

Simple access to global healthcare giants

Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.

Cost-effective

Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.

How to invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX.
  • Fund requires no minimum investment.

KEY FACTS

Pricing Information 22 October 2021

Current Price
Last Trade* -
% Change (prev day) -
Bid (delayed) -
Offer (delayed) -
* Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit* $7.64
* As at 20 October 2021

Profile

Net Assets* ($A) $148,813,845
Units Outstanding* (#) 19,480,459
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator Citigroup Pty Limited
Custodian Citigroup Pty Limited
Registry Link Market Services
Auditor KPMG
* As at 20 October 2021
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN Index
Index Methodology

Portfolio Holdings

Name Weight (%)
JOHNSON & JOHNSON 7.3
UNITEDHEALTH GROUP INC 6.7
ROCHE HOLDING AG 4.6
PFIZER INC 4.1
THERMO FISHER SCIENTIFIC INC 4.1
ABBOTT LABORATORIES 3.8
DANAHER CORP 3.5
NOVARTIS AG 3.5
MERCK & CO INC 3.5
ABBVIE INC 3.3
Ticker Name Weight (%) Asset Class Sector Country Currency Shares/Unit (#) Market Value (AUD) Notional Value (AUD)
JNJ UN JOHNSON & JOHNSON 7.3 Equities Healthcare United States USD 48,899 $10,701,978 $10,701,978
UNH UN UNITEDHEALTH GROUP INC 6.7 Equities Healthcare United States USD 16,639 $9,856,813 $9,856,813
ROG SE ROCHE HOLDING AG 4.6 Equities Healthcare Switzerland CHF 12,903 $6,734,782 $6,734,782
PFE UN PFIZER INC 4.1 Equities Healthcare United States USD 104,145 $5,978,643 $5,978,643
TMO UN THERMO FISHER SCIENTIFIC INC 4.1 Equities Healthcare United States USD 7,308 $5,955,345 $5,955,345
ABT UN ABBOTT LABORATORIES 3.8 Equities Healthcare United States USD 32,930 $5,515,532 $5,515,532
DHR UN DANAHER CORP 3.5 Equities Healthcare United States USD 12,465 $5,188,018 $5,188,018
NOVN SE NOVARTIS AG 3.5 Equities Healthcare Switzerland CHF 45,220 $5,115,698 $5,115,698
MRK UN MERCK & CO INC 3.5 Equities Healthcare United States USD 47,021 $5,112,101 $5,112,101
ABBV UN ABBVIE INC 3.3 Equities Healthcare United States USD 32,825 $4,781,740 $4,781,740
LLY UN ELI LILLY & CO 3.3 Equities Healthcare United States USD 14,748 $4,763,964 $4,763,964
AZN LN ASTRAZENECA PLC 3.0 Equities Healthcare Britain GBP 26,761 $4,382,615 $4,382,615
NOVOB DC NOVO NORDISK A/S 2.9 Equities Healthcare Denmark DKK 30,621 $4,280,134 $4,280,134
MDT UN MEDTRONIC PLC 2.8 Equities Healthcare United States USD 24,993 $4,072,326 $4,072,326
BMY UN BRISTOL-MYERS SQUIBB CO 2.2 Equities Healthcare United States USD 41,276 $3,196,043 $3,196,043
MRNA UW MODERNA INC 2.0 Equities Healthcare United States USD 6,298 $2,864,468 $2,864,468
ISRG UW INTUITIVE SURGICAL INC 1.9 Equities Healthcare United States USD 6,100 $2,774,904 $2,774,904
AMGN UW AMGEN INC 1.8 Equities Healthcare United States USD 9,387 $2,627,631 $2,627,631
SAN FP SANOFI 1.8 Equities Healthcare France EUR 19,714 $2,577,064 $2,577,064
ANTM UN ANTHEM INC 1.7 Equities Healthcare United States USD 4,302 $2,480,075 $2,480,075
ZTS UN ZOETIS INC 1.7 Equities Healthcare United States USD 8,804 $2,460,073 $2,460,073
SYK UN STRYKER CORP 1.6 Equities Healthcare United States USD 6,164 $2,282,315 $2,282,315
GSK LN GLAXOSMITHKLINE PLC 1.5 Equities Healthcare Britain GBP 86,923 $2,265,950 $2,265,950
EW UN EDWARDS LIFESCIENCES CORP 1.2 Equities Healthcare United States USD 11,578 $1,794,854 $1,794,854
BDX UN BECTON DICKINSON AND CO 1.2 Equities Healthcare United States USD 5,335 $1,761,207 $1,761,207
GILD UW GILEAD SCIENCES INC 1.2 Equities Healthcare United States USD 19,564 $1,755,414 $1,755,414
CI UN CIGNA CORP 1.2 Equities Healthcare United States USD 5,875 $1,701,515 $1,701,515
LONN SE LONZA GROUP AG 1.0 Equities Healthcare Switzerland CHF 1,383 $1,515,147 $1,515,147
HCA UN HCA HEALTHCARE INC 1.0 Equities Healthcare United States USD 4,281 $1,490,838 $1,490,838
BSX UN BOSTON SCIENTIFIC CORP 1.0 Equities Healthcare United States USD 24,597 $1,478,258 $1,478,258
EL FP ESSILORLUXOTTICA SA 1.0 Equities Consumer Discretionary France EUR 5,580 $1,474,503 $1,474,503
ILMN UW ILLUMINA INC 0.9 Equities Healthcare United States USD 2,500 $1,378,181 $1,378,181
7741 JT HOYA CORP 0.9 Equities Healthcare Japan JPY 6,600 $1,318,340 $1,318,340
BAYN GY BAYER AG 0.9 Equities Healthcare Germany EUR 17,154 $1,288,019 $1,288,019
IDXX UW IDEXX LABORATORIES INC 0.9 Equities Healthcare United States USD 1,486 $1,284,257 $1,284,257
HUM UN HUMANA INC 0.9 Equities Healthcare United States USD 2,029 $1,252,322 $1,252,322
DXCM UW DEXCOM INC 0.8 Equities Healthcare United States USD 1,600 $1,217,466 $1,217,466
2269 HK WUXI BIOLOGICS CAYMAN INC 0.8 Equities Healthcare China HKD 61,500 $1,198,279 $1,198,279
REGN UW REGENERON PHARMACEUTICALS INC 0.8 Equities Healthcare United States USD 1,543 $1,176,718 $1,176,718
IQV UN IQVIA HOLDINGS INC 0.8 Equities Healthcare United States USD 3,381 $1,154,050 $1,154,050
ALGN UW ALIGN TECHNOLOGY INC 0.8 Equities Healthcare United States USD 1,379 $1,107,282 $1,107,282
4502 JT TAKEDA PHARMACEUTICAL CO LTD 0.8 Equities Healthcare Japan JPY 29,300 $1,104,082 $1,104,082
VRTX UW VERTEX PHARMACEUTICALS INC 0.7 Equities Healthcare United States USD 4,288 $1,074,527 $1,074,527
A UN AGILENT TECHNOLOGIES INC 0.7 Equities Healthcare United States USD 4,904 $1,030,852 $1,030,852
VEEV UN VEEVA SYSTEMS INC 0.7 Equities Healthcare United States USD 2,361 $1,028,550 $1,028,550
ALC SE ALCON INC 0.7 Equities Healthcare Switzerland CHF 9,282 $1,015,536 $1,015,536
PHIA NA KONINKLIJKE PHILIPS NV 0.7 Equities Healthcare Netherlands EUR 15,849 $1,004,691 $1,004,691
BAX UN BAXTER INTERNATIONAL INC 0.7 Equities Healthcare United States USD 8,822 $962,550 $962,550
4568 JT DAIICHI SANKYO CO LTD 0.6 Equities Healthcare Japan JPY 28,600 $918,754 $918,754
CNC UN CENTENE CORP 0.6 Equities Healthcare United States USD 9,422 $870,645 $870,645
BIIB UW BIOGEN INC 0.6 Equities Healthcare United States USD 2,326 $841,828 $841,828
RMD UN RESMED INC 0.6 Equities Healthcare United States USD 2,382 $839,220 $839,220
ZBH UN ZIMMER BIOMET HOLDINGS INC 0.5 Equities Healthcare United States USD 3,685 $744,354 $744,354
WST UN WEST PHARMACEUTICAL SERVICES I 0.5 Equities Healthcare United States USD 1,195 $675,817 $675,817
4519 JT CHUGAI PHARMACEUTICAL CO LTD 0.4 Equities Healthcare Japan JPY 12,500 $569,430 $569,430
2413 JT M3 INC 0.4 Equities Healthcare Japan JPY 6,600 $567,739 $567,739
COLOB DC COLOPLAST A/S 0.4 Equities Healthcare Denmark DKK 2,501 $555,074 $555,074
068270 KP CELLTRION INC 0.3 Equities Healthcare South Korea KRW 1,691 $418,534 $418,534
DIM FP SARTORIUS STEDIM BIOTECH 0.2 Equities Healthcare France EUR 445 $334,824 $334,824
207940 KP SAMSUNG BIOLOGICS CO LTD 0.2 Equities Healthcare South Korea KRW 246 $242,987 $242,987
AUD AUD - AUSTRALIA DOLLAR FX Forwards AUD 147,494,301 $147,494,301
CHF CHF - SWISS FRANC FX Forwards CHF -9,491,169 -$13,845,615
DKK DKK - DANISH KRONE FX Forwards DKK -21,331,123 -$4,464,166
EUR EUR - EURO FX Forwards EUR -4,225,343 -$6,579,481
GBP GBP - BRITISH POUND FX Forwards GBP -3,572,913 -$6,601,957
HKD HKD - HONG KONG DOLLAR FX Forwards HKD -7,983,697 -$1,375,385
JPY JPY - JAPANESE YEN FX Forwards JPY -410,413,100 -$4,822,319
KRW KRW - KOREAN WON FX Forwards KRW -653,399,977 -$743,544
USD USD - UNITED STATES DOLLAR FX Forwards USD -78,180,156 -$104,714,916
Download CSV
* As at 21 October 2021. Excludes cash

Sector Allocation

Pharmaceuticals
42.2%
Health Care Equipment
21.2%
Biotechnology
11.4%
Managed Health Care
8.9%
Life Sciences Tools & Services
8.7%
Health Care Supplies
3.4%
Health Care Services
1.1%
Health Care Technology
1.1%
Apparel, Accessories & Luxury
1.0%
Other
1.0%
* As of 30 September 2021

Country Allocation

United States
73.1%
Switzerland
9.7%
Britain
4.6%
Japan
3.5%
Denmark
3.2%
France
3.0%
China
0.9%
Germany
0.9%
Netherlands
0.7%
South Korea
0.5%
* As of 30 September 2021

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month -4.97% -4.96%
3 months 1.53% 1.55%
6 months 10.52% 10.70%
1 year 18.02% 18.33%
3 year p.a 9.40% 9.63%
5 year p.a 11.37% 11.71%
Since inception (p.a) 10.19% 10.50%
Inception date 4-Aug-16 -
* As at 30 September 2021

Chart

Chart Type
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) 4.9%
12 Mth Gross Distribution Yield* (%) -
Franking Level -
*As at 30 September 2021. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
1-Jul-21 2-Jul-21 16-Jul-21 $0.34984 5.55%
4-Jan-21 5-Jan-21 19-Jan-21 $0.0166 1.00%
1-Jul-20 2-Jul-20 16-Jul-20 $0.04292 1.13%
2-Jan-20 3-Jan-20 17-Jan-20 $0.02494 0.46%
2-Jan-19 3-Jan-19 17-Jan-19 $0.01869 3.70%
2-Jul-18 3-Jul-18 17-Jul-18 $0.18445 3.77%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
Fund Flyer - DRUG
Download
Portfolio Holdings
Download
Product Disclosure Statement - Global Sector Series
Download
Product Disclosure Statement Update – 4 October 2021
Download
Product Disclosure Statement Update - 8 March 2021
Download
Annual Report - June 2021
Download
Interim Financial Report - December 2020
Download
NRWT and Fund Payment Notice information - June 2021 distributions
Download
NRWT and Fund Payment Notice information - December 2020 distributions
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack